As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...

The brain runs on energy. Every thought, memory, or emotion sparks countless signals between nerve cells. That communication ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.